Stepped-up philanthropic commitment, made on Giving Tuesday, will deepen the Company’s impact on local communities where its employees develop medical innovations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#GivingTuesday–Hologic, Inc. (Nasdaq: HOLX), a global leader in medical technology with a primary focus on improving women’s health, announced on Giving Tuesday that it will expand its philanthropic efforts with $5 million in donations to nonprofit organizations located near its major facilities over the coming year.
The increased giving will benefit causes that Hologic has long championed:
“Hologic’s philanthropy reflects the purpose that unites our employees around the world: to enable healthier lives everywhere, every day,” says Hologic Chairman, President and CEO Steve MacMillan. “We thank our purpose-driven team members and nonprofit partners for making a positive difference in the communities where they live and work.”
Hologic will contribute the $5 million mainly to charities serving areas where its facilities are located. The Company expects to donate:
The grants will be administered primarily through Hologic’s donor-advised fund at The San Diego Foundation. To learn about Hologic’s grant-making process, visit the Company’s philanthropy website.
Hologic chose to announce its $5 million pledge on Giving Tuesday because that movement’s mission aligns with Hologic’s guiding purpose. Established in 2012 as a one-day annual celebration of community-based generosity, Giving Tuesday has become a global phenomenon that encourages people to do good year-round.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about Hologic’s future philanthropic donations. There can be no assurance that these donations will be completed, or that they will have any impact on the Company’s share price. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
SOURCE: Hologic, Inc.
Contacts
Media Contact:
Darryl Ryan
858.410.7989 (direct)
619.507.9387 (mobile)
darryl.ryan@hologic.com
Investor Contacts:
Michael Watts (direct)
858.410.8588
michael.watts@hologic.com
Ryan Simon (direct)
858.410.8514
ryan.simon@hologic.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…